Inhibition of the AKT pathway in cholangiocarcinoma by MK2206 reduces cellular viability via induction of apoptosis

INTRODUCTION: Cholangiocarcinoma (CCA) is an aggressive disease with limited effective treatment options. The PI3K/Akt/mTOR pathway represents an attractive therapeutic target due to its frequent dysregulation in CCA. MK2206, an allosteric Akt inhibitor, has been shown to reduce cellular proliferati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Jacob M, Kunnimalaiyaan, Selvi, Kunnimalaiyaan, Muthusamy, Gamblin, T Clark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324843/
https://www.ncbi.nlm.nih.gov/pubmed/25674039
http://dx.doi.org/10.1186/s12935-015-0161-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324843/
https://www.ncbi.nlm.nih.gov/pubmed/25674039
http://dx.doi.org/10.1186/s12935-015-0161-9

Ejemplares similares